Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker

Overview of attention for article published in Frontiers in Medicine, January 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 1 X post from an account with 3,032 followers.

New Research: Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker: Purpose The value of… https://t.co/7cF1GUKsXj #medicalcare #cli

21 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.